Cargando…
Arsenic Trioxide Exerts Antimyeloma Effects by Inhibiting Activity in the Cytoplasmic Substrates of Histone Deacetylase 6
Arsenic trioxide (As(2)O(3)) has shown remarkable efficacy for the treatment of multiple myeloma (MM). Histone deacetylases (HDAC) play an important role in the control of gene expression, and their dysregulation has been linked to myeloma. Especially, HDAC6, a unique cytoplasmic member of class II,...
Autores principales: | Qu, Xiaoyan, Du, Juan, Zhang, Chunyang, Fu, Weijun, Xi, Hao, Zou, Jianfeng, Hou, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284565/ https://www.ncbi.nlm.nih.gov/pubmed/22384180 http://dx.doi.org/10.1371/journal.pone.0032215 |
Ejemplares similares
-
Beyond Histone and Deacetylase: An Overview of Cytoplasmic Histone Deacetylases and Their Nonhistone Substrates
por: Yao, Ya-Li, et al.
Publicado: (2011) -
Chemosensitivity enhancement toward arsenic trioxide by inhibition of histone deacetylase in NB4 cell line
por: Li, Xiaofan, et al.
Publicado: (2016) -
Homoharringtonine Exerts an Antimyeloma Effect by Promoting Excess Parkin-Dependent Mitophagy
por: Zhang, Yanyu, et al.
Publicado: (2020) -
Chidamide epigenetically represses autophagy and exerts cooperative antimyeloma activity with bortezomib
por: Xu, Li, et al.
Publicado: (2020) -
Bisphosphonates as antimyeloma drugs
por: Modi, N D, et al.
Publicado: (2012)